Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Altimmune (ALT) FCF Margin (2016 - 2025)

Historic FCF Margin for Altimmune (ALT) over the last 17 years, with Q3 2025 value amounting to 237940.0%.

  • Altimmune's FCF Margin rose 3044200000.0% to 237940.0% in Q3 2025 from the same period last year, while for Sep 2025 it was 331760.0%, marking a year-over-year decrease of 1815369200.0%. This contributed to the annual value of 399240.0% for FY2024, which is 3814331900.0% down from last year.
  • According to the latest figures from Q3 2025, Altimmune's FCF Margin is 237940.0%, which was up 3044200000.0% from 387000.0% recorded in Q2 2025.
  • In the past 5 years, Altimmune's FCF Margin ranged from a high of 674.82% in Q4 2021 and a low of 755500.0% during Q3 2022
  • Over the past 5 years, Altimmune's median FCF Margin value was 209037.5% (recorded in 2022), while the average stood at 217497.97%.
  • In the last 5 years, Altimmune's FCF Margin crashed by 2000000000bps in 2022 and then soared by 2000000000bps in 2023.
  • Altimmune's FCF Margin (Quarter) stood at 674.82% in 2021, then crashed by -9785bps to 66707.69% in 2022, then surged by 33bps to 44683.78% in 2023, then plummeted by -718bps to 365300.0% in 2024, then skyrocketed by 35bps to 237940.0% in 2025.
  • Its FCF Margin stands at 237940.0% for Q3 2025, versus 387000.0% for Q2 2025 and 336800.0% for Q1 2025.